| Fibrocell Science is an autologous cell and gene therapy company focused on translating personalized biologics for diseases affecting the skin and connective tissue. Co.'s development programs consist of the following: FCX-007, which is a genetically-modified autologous fibroblast that encodes the gene for type VII collagen for localized treatment of recessive dystrophic epidermolysis bullosa; FCX-013, which is an autologous fibroblast genetically-modified using lentivirus and encoded for matrix metalloproteinase 1; and Gene Therapy Research Program, which is in the research phase and is focused on the treatment of arthritis and related conditions. We show 8 historical shares outstanding datapoints in our coverage of FCSC's shares outstanding history.|
Understanding the changing numbers of FCSC shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like FCSC versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching FCSC by allowing them to research FCSC shares outstanding history
as well as any other stock in our coverage universe.